Generation of Genetically Engineered Non-human Primate Models of Brain Function and Neurological Disorders

Overview

Journal Am J Primatol

Date 2018 Dec 27

PMID 30585654

Citations 16

Authors

Jung Eun Park

Afonso C Silva

Affiliations

Soon will be listed here.

Abstract

Research with non-human primates (NHP) has been essential and effective in increasing our ability to find cures for a large number of diseases that cause human suffering and death. Extending the availability and use of genetic engineering techniques to NHP will allow the creation and study of NHP models of human disease, as well as broaden our understanding of neural circuits in the primate brain. With the recent development of efficient genetic engineering techniques that can be used for NHP, there's increased hope that NHP will significantly accelerate our understanding of the etiology of human neurological and neuropsychiatric disorders. In this article, we review the present state of genetic engineering tools used in NHP, from the early efforts to induce exogeneous gene expression in macaques and marmosets, to the latest results in producing germline transmission of different transgenes and the establishment of knockout lines of specific genes. We conclude with future perspectives on the further development and employment of these tools to generate genetically engineered NHP.

Citing Articles

Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes.

Rust L, Wettengel J, Biswas S, Ryu J, Piekarski N, Yusova S Proc Natl Acad Sci U S A. 2025; 122(7):e2413771122.

PMID: 39937851 PMC: 11848295. DOI: 10.1073/pnas.2413771122.

Human-derived monoclonal autoantibodies as interrogators of cellular proteotypes in the brain.

Baum M, Bartley C Trends Neurosci. 2024; 47(10):753-765.

PMID: 39242246 PMC: 11656492. DOI: 10.1016/j.tins.2024.08.004.

High resolution dynamic ultrasound atlas of embryonic and fetal development of the common marmoset.

Soman R, Fabiszak M, McPhee M, Schade P, Freiwald W, Brivanlou A J Assist Reprod Genet. 2024; 41(5):1319-1328.

PMID: 38446290 PMC: 11143105. DOI: 10.1007/s10815-024-03072-2.

Bridging the rodent to human translational gap: Marmosets as model systems for the study of Alzheimer's disease.

Sukoff Rizzo S, Homanics G, Schaeffer D, Schaeffer L, Park J, Oluoch J Alzheimers Dement (N Y). 2023; 9(3):e12417.

PMID: 37614242 PMC: 10442521. DOI: 10.1002/trc2.12417.

An efficient evaluation system for factors affecting the genome editing efficiency in mouse.

Sakai Y, Okabe Y, Itai G, Shiozawa S Exp Anim. 2023; 72(4):526-534.

PMID: 37407493 PMC: 10658088. DOI: 10.1538/expanim.23-0045.

References

Gaudelli N, Komor A, Rees H, Packer M, Badran A, Bryson D . Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature. 2017; 551(7681):464-471. PMC: 5726555. DOI: 10.1038/nature24644. View

Tan W, Proudfoot C, Lillico S, Whitelaw C . Gene targeting, genome editing: from Dolly to editors. Transgenic Res. 2016; 25(3):273-87. PMC: 4882362. DOI: 10.1007/s11248-016-9932-x. View

Chen Y, Niu Y, Li Y, Ai Z, Kang Y, Shi H . Generation of Cynomolgus Monkey Chimeric Fetuses using Embryonic Stem Cells. Cell Stem Cell. 2015; 17(1):116-24. DOI: 10.1016/j.stem.2015.06.004. View

Moran S, Chi T, Prucha M, Ahn K, Connor-Stroud F, Jean S . Germline transmission in transgenic Huntington's disease monkeys. Theriogenology. 2015; 84(2):277-85. PMC: 4631054. DOI: 10.1016/j.theriogenology.2015.03.016. View

Bak R, Gomez-Ospina N, Porteus M . Gene Editing on Center Stage. Trends Genet. 2018; 34(8):600-611. DOI: 10.1016/j.tig.2018.05.004. View

Huang L, Merson T, Bourne J . In vivo whole brain, cellular and molecular imaging in nonhuman primate models of neuropathology. Neurosci Biobehav Rev. 2016; 66:104-18. DOI: 10.1016/j.neubiorev.2016.04.009. View

Chen Y, Carter R, Cho I, Chan A . Cell-based therapies for Huntington's disease. Drug Discov Today. 2014; 19(7):980-4. PMC: 4082729. DOI: 10.1016/j.drudis.2014.02.012. View

Chen Y, Cui Y, Shen B, Niu Y, Zhao X, Wang L . Germline acquisition of Cas9/RNA-mediated gene modifications in monkeys. Cell Res. 2014; 25(2):262-5. PMC: 4650569. DOI: 10.1038/cr.2014.167. View

Lane M . Nonhuman primate models in biogerontology. Exp Gerontol. 2000; 35(5):533-41. DOI: 10.1016/s0531-5565(00)00102-9. View

10.

Chen Y, Zheng Y, Kang Y, Yang W, Niu Y, Guo X . Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9. Hum Mol Genet. 2015; 24(13):3764-74. PMC: 5007610. DOI: 10.1093/hmg/ddv120. View

11.

Ke Q, Li W, Lai X, Chen H, Huang L, Kang Z . TALEN-based generation of a cynomolgus monkey disease model for human microcephaly. Cell Res. 2016; 26(9):1048-61. PMC: 5034111. DOI: 10.1038/cr.2016.93. View

12.

Wan H, Feng C, Teng F, Yang S, Hu B, Niu Y . One-step generation of p53 gene biallelic mutant Cynomolgus monkey via the CRISPR/Cas system. Cell Res. 2014; 25(2):258-61. PMC: 4650568. DOI: 10.1038/cr.2014.158. View

13.

Scheikl T, Pignolet B, Mars L, Liblau R . Transgenic mouse models of multiple sclerosis. Cell Mol Life Sci. 2010; 67(23):4011-34. PMC: 11115830. DOI: 10.1007/s00018-010-0481-9. View

14.

Liu H, Chen Y, Niu Y, Zhang K, Kang Y, Ge W . TALEN-mediated gene mutagenesis in rhesus and cynomolgus monkeys. Cell Stem Cell. 2014; 14(3):323-328. PMC: 4024384. DOI: 10.1016/j.stem.2014.01.018. View

15.

Izpisua Belmonte J, Callaway E, Caddick S, Churchland P, Feng G, Homanics G . Brains, genes, and primates. Neuron. 2015; 86(3):617-31. PMC: 4425847. DOI: 10.1016/j.neuron.2015.03.021. View

16.

Carter R, Chan A . Pluripotent stem cells models for Huntington's disease: prospects and challenges. J Genet Genomics. 2012; 39(6):253-9. PMC: 4075320. DOI: 10.1016/j.jgg.2012.04.006. View

17.

Hirano Y, Yen C, Liu J, Mackel J, Merkle H, Nascimento G . Investigation of the BOLD and CBV fMRI responses to somatosensory stimulation in awake marmosets (Callithrix jacchus). NMR Biomed. 2017; 31(3). PMC: 5841465. DOI: 10.1002/nbm.3864. View

18.

Mitalipov S, Zhou Q, Byrne J, Ji W, Norgren R, Wolf D . Reprogramming following somatic cell nuclear transfer in primates is dependent upon nuclear remodeling. Hum Reprod. 2007; 22(8):2232-42. DOI: 10.1093/humrep/dem136. View

19.

Bales K . The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update. Expert Opin Drug Discov. 2012; 7(4):281-97. DOI: 10.1517/17460441.2012.666234. View

20.

Silva A . Anatomical and functional neuroimaging in awake, behaving marmosets. Dev Neurobiol. 2016; 77(3):373-389. PMC: 5318267. DOI: 10.1002/dneu.22456. View